Type 2 Cardiorenal Syndrome: Prevalence and Correlates in Nigerian Heart Failure Patients

Daniel Gilbert Uchendu1, Basil Nwaneri Okeahialam2, Lucius Chidiebere Imoh3

  • 1Renal Unit, Department of Medicine, Jos University Teaching Hospital, Plateau State, Nigeria.

Insights

Type 2 cardiorenal syndrome (CRS) affects 37.5% of heart failure patients, with diabetes and heart dysfunction as key predictors. Early CKD screening in heart failure patients is crucial to prevent severe kidney disease.

Area of Science:

  • Cardiology
  • Nephrology
  • Internal Medicine

Background:

  • Type 2 cardiorenal syndrome (CRS) links chronic congestive heart failure (HF) to progressive chronic kidney disease (CKD).
  • HF and CKD share cardiovascular risk factors and exhibit a bi-directional relationship.
  • A multidisciplinary approach is vital for reducing morbidity and mortality in these patients.

Purpose of the Study:

  • To determine the prevalence of Type 2 CRS among heart failure patients.
  • To identify correlates and predictors of Type 2 CRS in this population.
  • To assess the burden of cardiorenal syndrome in Jos, Nigeria.

Main Methods:

  • A hospital-based cross-sectional descriptive study was conducted.
  • 120 patients with chronic heart failure were consecutively recruited.
  • CKD was diagnosed using estimated glomerular filtration rate (eGFR) and persistent albuminuria.

Main Results:

  • The prevalence of Type 2 CRS was 37.5%, with most cases being mild (66.7%).
  • Key predictors identified include diabetes, NYHA grade, jugular venous pressure, loud P2, systolic dysfunction, anemia, albuminuria, dwelling location, and cardiothoracic ratio.
  • Significant predictors like diabetes (OR=6.230) and raised JVP (OR=7.099) were noted.

Conclusions:

  • The prevalence of Type 2 CRS among chronic heart failure patients in Jos, Nigeria, is high.
  • Early screening for CKD in heart failure patients and timely nephrologist referral are essential.
  • Interventions targeting identified predictors can help prevent progression to end-stage renal disease (ESRD).
Abstract

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
44
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
510
Heart Failure VII: Nursing Interventions01:30

Heart Failure VII: Nursing Interventions

The first step in nursing management of a patient with heart failure involves thoroughly assessing the patient's medical history.Subjective Data: Obtain the patient's medical history of coronary artery disease, hypertension, myocardial infarction, and symptoms like dyspnea, orthopnea, and paroxysmal nocturnal dyspnea.Objective Data: Conduct a physical examination to identify findings such as jugular vein distention, pulmonary crackles, tachycardia, murmurs, peripheral edema, and vital signs,...
140
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
96
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
55
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.8K